Managed Healthcare Executive April 16, 2024
Peter Wehrwein, Managing Editor

Ross Margulies, J.D., M.P.H., a partner at the Foley Hoag law firm, discusses whether proposed transparency rules in the pharmacy benefit manager (PBM) legislation that Congress is considering might apply to the PBM-affiliated group purchasing organizations.

The pharmacy benefit manager (PBM) bills that Congress is currently considering include a variety of new transparency and reporting rules. Whether those rules would apply to the group purchasing organizations (GPOs) affiliated with the major PBMs is an open question

Ross Margulies, J.D., M.P.H., a partner at Foley Hoag, a law firm...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Trends
Project Optimus: helping or hindering cancer drug development?
Faster Drug Discovery: Yseop & AWS Unveils GenAI Tool for Biopharma R&D
Quest to ramp up AI capabilities with purchase of PathAI’s diagnostic lab
STAT+: Gilead gets a boost from California court in a case over slow-walking an HIV drug
Specialty Pharmacies Drive Cost Savings in Value-Based Care | Asembia 2024

Share This Article